NBY NovaBay Pharmaceuticals, Inc. Stock Quote

NBY [AMEX]

Index	-	P/E	-	EPS (ttm)	-0.41	Insider Own	9.60%	Shs Outstand	40.04M	Perf Week	28.78%
Market Cap	42.71M	Forward P/E	-	EPS next Y	-0.15	Insider Trans	-25.12%	Shs Float	31.25M	Perf Month	52.94%
Income	-12.80M	PEG	-	EPS next Q	-0.05	Inst Own	6.20%	Short Float	3.28%	Perf Quarter	41.82%
Sales	9.80M	P/S	4.36	EPS this Y	-25.30%	Inst Trans	-	Short Ratio	0.54	Perf Half Y	-35.40%
Book/sh	0.35	P/B	2.97	EPS next Y	53.10%	ROA	-100.10%	Target Price	-	Perf Year	65.57%
Cash/sh	0.33	P/C	3.19	EPS next 5Y	-	ROE	-329.80%	52W Range	0.24 - 1.94	Perf YTD	49.21%
Dividend	-	P/FCF	-	EPS past 5Y	42.40%	ROI	-261.30%	52W High	-46.39%	Beta	3.78
Dividend %	-	Quick Ratio	5.10	Sales past 5Y	44.30%	Gross Margin	61.50%	52W Low	333.33%	ATR	0.09
Employees	28	Current Ratio	5.30	Sales Q/Q	37.50%	Oper. Margin	-70.30%	RSI (14)	69.72	Volatility	15.71% 9.94%
Optionable	No	Debt/Eq	0.01	EPS Q/Q	-558.90%	Profit Margin	-	Rel Volume	3.14	Prev Close	0.91
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 12 AMC	Payout	-	Avg Volume	1.90M	Price	1.04
Recom	1.50	SMA20	37.22%	SMA50	53.35%	SMA200	19.84%	Volume	5,970,508	Change	13.89%

Sep-18-19

Initiated

Ladenburg Thalmann

Buy

$1.10

Jul-06-18

Reiterated

H.C. Wainwright

Buy

Nov-15-17

Reiterated

Laidlaw

Buy

$10 → $8

Jun-05-17

Initiated

ROTH Capital

Buy

$5.50

Mar-27-17

Initiated

Laidlaw

Buy

$10

Feb-06-17

Initiated

Rodman & Renshaw

Buy

Mar-07-16

Downgrade

Maxim Group

Buy → Hold

Dec-14-15

Reiterated

Maxim Group

Buy

$1 → $0.23

Apr-30-15

Resumed

Maxim Group

Buy

Mar-06-13

Initiated

Ascendiant Capital Markets

Strong Buy

$2.25

Jan-03-08

Initiated

Dawson James

Speculative Buy

Dec-14-20 06:50AM	NovaBay Pharmaceuticals Now Included in EPA N Listing of Products That Kill SARS-CoV-2 Business Wire
Nov-23-20 06:50AM	NovaBay Pharmaceuticals Expands Avenovas Geographic Reach to Australia with New Exclusive Distribution Agreement Business Wire
Nov-12-20 04:05PM	NovaBay Pharmaceuticals Reports Third Quarter 2020 Financial Results Business Wire +5.55%
02:30PM	NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
06:50AM	NovaBay Announces Consumer Launch of CelleRx® Clinical Reset Business Wire
Nov-03-20 04:11PM	Why NovaBay's Stock Is Trading Lower Today Benzinga -15.45%
Oct-30-20 06:50AM	NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November 12 Business Wire
Oct-12-20 06:50AM	NovaBay Pharmaceuticals Regains Compliance with NYSE American Listing Standards Business Wire
Sep-24-20 06:50AM	NovaBay Pharmaceuticals Expands Avenova® Consumer Marketing through Affiliate Programs and Enhanced Lifestyle Public Relations Business Wire
Sep-08-20 06:50AM	NovaBay Announces that Avenova is Now Available with "Subscribe & Save" Business Wire
Aug-24-20 06:50AM	NovaBay Appoints CEO Justin Hall to its Board of Directors Business Wire
Aug-18-20 12:05PM	Why NovaBay's Stock Is Trading Higher Today Benzinga +10.42%
06:50AM	NovaBay Expands Avenovas Online Distribution Business Wire
Aug-06-20 04:05PM	NovaBay Pharmaceuticals Reports Second Quarter 2020 Financial Results Business Wire
Jul-27-20 06:50AM	NovaBay Pharmaceuticals to Hold Second Quarter 2020 Conference Call on August 6 Business Wire
Jul-13-20 06:50AM	NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2 (COVID-19 Virus) Business Wire +23.89%
May-14-20 06:50AM	NovaBay Pharmaceuticals Issues Letter to Stockholders Business Wire
May-07-20 04:05PM	NovaBay Pharmaceuticals Reports First Quarter 2020 Financial Results Business Wire
May-05-20 02:05PM	CORRECTING and REPLACING NovaBay Pharmaceuticals Appoints Andrew D. Jones Chief Financial Officer Business Wire -5.63%
Apr-27-20 04:15PM	NovaBay Pharmaceuticals to Hold First Quarter 2020 Conference Call on May 7, 2020 Business Wire +6.73%
Apr-20-20 06:50AM	NovaBay Pharmaceuticals Signs Agreement to Distribute COVID-19 Antibody Rapid Point-of-Care Test to U.S. Healthcare Professionals Business Wire +69.74%
Mar-26-20 04:05PM	NovaBay Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results Business Wire
02:30PM	NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-25-20 06:50AM	NovaBay Pharmaceuticals Announces the Availability of KN95 Disposable Masks on Avenova.com Business Wire +7.60%
Mar-23-20 06:50AM	NovaBay Pharmaceuticals Unveils Refreshed Consumer Branding for Online Sales of Avenova® Antimicrobial Lid & Lash Solution Business Wire +8.03%
Mar-19-20 06:50AM	NovaBay Pharmaceuticals to Hold 2019 Fourth Quarter and Full Year Conference Call on March 26, 2020 Business Wire +394.40%
Dec-02-19 06:50AM	NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com Business Wire +5.09%
Nov-18-19 06:50AM	NovaBay Pharmaceuticals Launches NovaSight Daily Vitamin for Ocular Health on Amazon.com Business Wire +29.78%
Nov-07-19 04:05PM	NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results Business Wire +9.42%
Nov-04-19 06:50AM	NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology and Cosmetic Surgery Procedures Business Wire +25.54%
Oct-31-19 06:50AM	NovaBay Pharmaceuticals to Hold Third Quarter 2019 Conference Call on November 7, 2019 Business Wire
Oct-28-19 06:50AM	NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies Business Wire
Sep-24-19 02:20PM	Market Morning: Prorogation Ruled Rogue, High Demand for Fed Repo, New Breast Cancer Tests Market Exclusive
06:50AM	NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia Business Wire
Sep-16-19 06:50AM	NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors Business Wire
Aug-09-19 09:26AM	NovaBay Pharmaceuticals Announces Pricing of $2.7 Million Private Placement of Preferred Stock and Accompanying Warrants to Purchase Common Stock GlobeNewswire -17.29%
09:22AM	NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering GlobeNewswire
Aug-07-19 06:50AM	NovaBay Pharmaceuticals Reports 2019 Second Quarter Financial Results Business Wire -6.78%
Jul-29-19 06:50AM	NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million Business Wire +34.31%
Jul-15-19 06:50AM	NovaBay Pharmaceuticals Issues Letter to Stockholders Business Wire
Jul-01-19 10:17AM	NovaBay Trades Higher After Compliance Plan Accepted By NYSE Benzinga
06:50AM	NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE Business Wire
Jun-26-19 04:05PM	NovaBay Pharmaceuticals Raises $2.4 Million in a Private Placement Business Wire
Jun-17-19 06:50AM	NovaBay Pharmaceuticals Appoints Justin Hall President and CEO, and Jason Raleigh CFO Business Wire +5.42%
Jun-10-19 01:52PM	NovaBay's stock halted for volatility 18 times as it rockets 557% MarketWatch +874.84%
07:55AM	NovaBay's stock more than triples after Avenova made available on Amazon without prescription MarketWatch
06:50AM	NovaBay Pharmaceuticals Launches Avenova® Direct on Amazon.com Business Wire
May-21-19 04:05PM	NovaBay Pharmaceuticals Receives NYSE American Communication Business Wire
May-09-19 04:05PM	NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results Business Wire -33.65%
Apr-30-19 06:50AM	NovaBay Pharmaceuticals to Hold First Quarter 2019 Conference Call on May 9, 2019 Business Wire
Apr-17-19 06:50AM	NovaBay Pharmaceuticals Announces Annual Meeting of Stockholders and Receives NYSE American Communication Business Wire -9.26%
Apr-15-19 06:50AM	NovaBay Pharmaceuticals Announces New Partner Pharmacy Program Business Wire +9.46%
Mar-28-19 04:05PM	NovaBay Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results Business Wire
02:30PM	NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-12-19 04:05PM	NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy Business Wire +7.91%
10:30AM	Analysts Estimate NovaBay Pharmaceuticals (NBY) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-07-19 06:50AM	NovaBay Pharmaceuticals Announces Preliminary 2018 Net Sales and Introduces 2019 Net Sales Guidance Business Wire
Nov-14-18 04:05PM	NovaBay Pharmaceuticals Reports Third Quarter 2018 Financial Results Business Wire
Nov-07-18 06:50AM	NovaBay Pharmaceuticals to Hold Third Quarter 2018 Conference Call on November 14, 2018 Business Wire
Nov-06-18 10:30AM	Will NovaBay Pharmaceuticals (NBY) Report Negative Earnings Next Week? What You Should Know Zacks
Sep-28-18 06:50AM	NovaBay Pharmaceuticals Names Jack McGovern Interim CEO Business Wire
Aug-30-18 08:00AM	NovaBay Pharmaceuticals to Present at H.C. Wainwright 20th Annual Global Investment Conference on September 6 Business Wire +8.82%
Aug-07-18 04:05PM	NovaBay Pharmaceuticals Reports Second Quarter 2018 Financial Results Business Wire
02:30PM	NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 06:50AM	NovaBay Pharmaceuticals to Hold Second Quarter 2018 Conference Call on August 7, 2018 Business Wire +8.89%
Jul-05-18 06:50AM	NovaBay Pharmaceuticals Expands Sales Organization to Re-energize Growth Business Wire
May-10-18 04:05PM	NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results Business Wire
May-07-18 06:50AM	NovaBay Pharmaceuticals to Hold First Quarter 2018 Conference Call on May 10, 2018 Business Wire
Mar-20-18 04:05PM	NovaBay Pharmaceuticals Reports 2017 Fourth Quarter and Full Year Financial Results Business Wire
12:00PM	NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
07:41AM	NovaBay Pharmaceuticals Q4 Earnings Outlook Benzinga
Mar-01-18 10:49PM	BRIEF-Jinzi Ham's Unit Scraps Plan To Invest In Novabay Pharma, To Boost Asset Management Subsidiary's Capital Reuters
03:53AM	BRIEF-Jinzi Ham's Unit Scraps Plan To Invest In Novabay Pharma, To Boost Asset Management Subsidiary's Capital Reuters
Feb-21-18 06:50AM	NovaBay Pharmaceuticals to Hold 2017 Fourth Quarter and Full Year Conference Call on March 20, 2018 Business Wire
Feb-12-18 06:50AM	NovaBay Pharmaceuticals Completes $6.0 Million Private Placement Business Wire
Jan-08-18 06:50AM	NovaBay Pharmaceuticals Announces Preliminary Sales for 2017 Fourth Quarter and Full Year Business Wire
Dec-22-17 06:50AM	NovaBay Pharmaceuticals Receives Stockholder Approval for Proposed $10.32 Million Financing Agreement Business Wire
Dec-21-17 06:50AM	NovaBay Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards Business Wire
Dec-19-17 01:41PM	ETFs with exposure to NovaBay Pharmaceuticals, Inc. : December 19, 2017 Capital Cube
Dec-06-17 06:50AM	NovaBay Pharmaceuticals Names Lewis J. Stuart Chief Commercial Officer Business Wire
Nov-30-17 02:09PM	ETFs with exposure to NovaBay Pharmaceuticals, Inc. : November 30, 2017 Capital Cube
Nov-29-17 08:02AM	NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-14-17 04:05PM	NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results Business Wire
11:00AM	NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
05:01AM	BRIEF-Jinzi Ham's unit to invest in Novabay Pharma and become its biggest shareholder Reuters
Nov-07-17 06:50AM	NovaBay Pharmaceuticals to Hold Third Quarter 2017 Conference Call on November 14 Business Wire
Sep-26-17 09:00AM	Dry Eye Advances from NovaBay and Johnson & Johnson Vision's TearScience ACCESSWIRE
Sep-20-17 06:50AM	NovaBay Pharmaceuticals Receives Notification of Noncompliance with Additional NYSE American Continued Listing Standards Business Wire
Sep-19-17 06:10PM	ETFs with exposure to NovaBay Pharmaceuticals, Inc. : September 19, 2017 Capital Cube
Sep-18-17 12:01PM	NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017 Capital Cube
09:00AM	Eye Surgeon Says Keep Eyelids Healthy with Avenova from NovaBay ACCESSWIRE
Sep-05-17 06:50AM	NovaBay Pharmaceuticals to Present at Rodman & Renshaw 19th Annual Global Investment Conference Business Wire
Aug-14-17 09:00AM	NovaBay's Avenova Offers Key Benefits in Glaucoma Care ACCESSWIRE
Aug-10-17 04:05PM	NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results Business Wire
02:00PM	Investor Network: NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 06:50AM	NovaBay Pharmaceuticals to Hold 2017 Second Quarter Conference Call on August 10, 2017 Business Wire
Jul-24-17 10:00AM	Fighting Parasitic Eyelid Mites with Avenova from NovaBay Pharmaceuticals Accesswire
Jul-10-17 01:32PM	UPDATE: NovaBay's Avenova Highlighted in National Dry Eye Awareness Month Accesswire
10:00AM	NovaBay's Avenova Highlighted in National Dry Eye Awareness Month Accesswire
06:50AM	NovaBay Pharmaceuticals Announces CFO Transition Business Wire

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products to address therapeutic needs of the anti-infective market in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx for the aesthetic dermatology market; and NeutroPhase for the wound care market. It also develops auriclosene, a synthetic molecule for use against bacteria, viruses, and fungi. The company has a collaboration and license agreement with Virbac to develop auriclosene for veterinary markets for companion animals. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WU MIJIA	Director	Aug 17	Sale	1.35	20,000	27,000	0	Aug 19 04:24 PM
Fu Jian Ping	10% Owner	Aug 01	Sale	1.23	1,302,350	1,601,891	4,000,000	Aug 04 06:04 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience